Executive record

SoYoung Kwon

SVP, General Counsel, Business Development and Corporate Affairs at Aptevo Therapeutics Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:soyoung-kwonVersion: public-0As of: 2026-09-29

Not yet claimed7 published Claims2 sources
  • Counsel

Key Claims

Biography

Previously served as Global Senior Vice President, General Counsel and Corporate Secretary at AGC Biologics and Vice President, General Counsel and Corporate Secretary at CMC Biologics and Onvia, Inc.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedSVP, General Counsel, Business Development and Corporate Affairs · Aptevo Therapeutics Inc.
  2. 2026 to end not publishedExecutive title: Senior Vice President, General Counsel, Business Development and Corporate Affairs · Organization not publishedAPVO 10-K executive officers
  3. Dates not publishedExecutive title: SVP, General Counsel, Business Development and Corporate Affairs · Organization not published

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Aug 31, 2026 · Retrieved: Sep 5, 2026

    Supports 2 claims
    • Professional Role: SVP, General Counsel, Business Development and Corporate Affairs at Aptevo Therapeutics Inc. · Claim reviewed: Sep 5, 2026
    • Executive title: Executive title: SVP, General Counsel, Business Development and Corporate Affairs · Claim reviewed: Sep 5, 2026

  2. APVO 10-K executive officers

    sec filing · Source published: Mar 26, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Aptevo Therapeutics Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Senior Vice President, General Counsel, Business Development and Corporate Affairs · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026